Summit Therapeutics Share Discussion Threads

[someuwin] 25/1/2018 14:29

Fantastic news.

[ohsod1t] 25/1/2018 14:24

I'm surprised at the small reaction. 25% from possibility to success. Hopefully more to come.

[phowdo] 25/1/2018 14:20

$16.00 pre-market on Nasdaq. +31%

[football] 25/1/2018 14:11

Summit Therapeutics a star performer in London on release of positive interim data from PhaseOut DMD trial
Share
12:30 25 Jan 2018
"These data provide the first evidence of utrophin modulation working in patients. If further findings build on this evidence they could establish ezutromid as a universal, disease-modifying treatment and bring hope to all patients and families living with DMD."

read more

[hugus maximus] 25/1/2018 13:58

AIM seems pretty weak in its response ... be interesting to see how strong the NASDAQ is today. I got the impression from the phone in that the results were strong enough for a chance of accelerated approval being set up before 48 wk results? Although there's not enough significant walk test data yet, I wonder how this compares for example with eteplirsen accelerated approval data?

[waterloo01] 25/1/2018 13:56

Some good questions that will need further data analysis to answer. I think the key thing, apart from how 'excited' Glyn is, that it seems to work as demonstrated in the Biopsies and MRI.

[solomon] 25/1/2018 13:53

Lots of congratulatory remarks from analysts.
Glyn very thankful to the patients who have been involved

[chrisatrdg] 25/1/2018 13:51

More people than ever before ringing in on the call obviously these results have excited a lot of people.

[waterloo01] 25/1/2018 13:48

Assume we'll get some interviews later.

[algernon2] 25/1/2018 13:45

Quite a lot of analysts interests as shown by the ongoing Q and A.
Bodes well for later when the news is disseminated more widely over the pond.
Glued to my webcast.My Tea tasted less bitter than usual as I drink it.

[solomon] 25/1/2018 13:45

53k trades on Nasdaq premarket

[hugus maximus] 25/1/2018 13:40

Indeed algernon2 ... that seems bizarre and contrary to expectations. Maybe a statistical thing that will change with more than a couple of boys in the data. It seems to suggest there's a threshold effect ion this continues through ... early days.

[waterloo01] 25/1/2018 13:37

Very early look at the data, so more to come as they present at conferences. Odd re F3/F6, although they always said they thought both would work. Key thing is it shows it works. Proof of concept.

[algernon2] 25/1/2018 13:34

Looks like no immediate difference in any of the Boys responses between those on F3 and those on F6. Interesting.

[ohsod1t] 25/1/2018 13:24

They seem happy to take large volume sells. Must have someone in mind for them.

[hugus maximus] 25/1/2018 13:17

Some folk on AIM making a few bob and selling out before more buy in.

[hugus maximus] 25/1/2018 13:16

and Sarepta will have to get involved if they wish to continue with a DMD drug that helps 100% of boys as per these results.

[hugus maximus] 25/1/2018 13:16

The FDA will LOVE that!

[waterloo01] 25/1/2018 13:13

Robust study. FDA will like that.

[algernon2] 25/1/2018 13:10

Webcast on live now via Summit site.

[hugus maximus] 25/1/2018 12:52

Bet you're having a big family party in Reading!

[chrisatrdg] 25/1/2018 12:49

So right you are waterloo01 !!

[waterloo01] 25/1/2018 12:47

and your sisters will finally speak to you again!

[waterloo01] 25/1/2018 12:46

Need to look at broker notes but the new ones will be interesting. What TP now?